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A commentary on
Cognitive and neuroplasticity mech-
anisms by which congenital or early
blindness may confer a protective effect
against schizophrenia
by Silverstein, S. M., Wang, Y., and Keane,
B. P. (2012). Front. Psychol. 3:624. doi:
10.3389/fpsyg.2012.00624
Our paper on congenital and early (C/E)
blindness and schizophrenia was an effort
to account for the previously reported
negative relationship between these con-
ditions, in light of recent work indicating
what the study of C/E blind people reveals
about brain function and organization
(Cattaneo and Vecchi, 2011; Kupers et al.,
2011; Ricciardi and Pietrini, 2011). In par-
ticular, we hypothesized that the neuro-
plastic changes inherent to C/E blindness
protect against schizophrenia by promot-
ing strengths in those cognitive domains
where schizophrenia is characterized by
deficits.
Since our paper was published, we have
received several comments asking a ver-
sion of this question: can the lack of
reports of people with both conditions be
explained simply by the rarity of each con-
dition, so that the chances of a person
having both are so low that even if such
people existed, it is unlikely their condi-
tion will have been reported? This is an
important question, as when studying low
base rate phenomena, distorted conclu-
sions can easily be reached (Meehl and
Rosen, 1955). We addressed this issue in
the original version of our manuscript, but
then removed it from the final version due
to length considerations. Here, we note
our earlier comments.
The conclusion that there are no
C/E blind people with schizophrenia is
based on a small number of studies that
involved relatively small samples. Clearly,
this argument would be strengthened by
larger, population-based studies. This is
because, as a simple calculation demon-
strates, a case of congenital blindness and
schizophrenia would be extremely rare
even if there was no protective effect
of blindness: if schizophrenia occurs
at a rate of 0.72% in the population
(McGrath et al., 2008), and congenital
blindness occurs at an estimated rate of
0.03% in people born in the 1970s and
1980s (based on Robinson et al., 1987),
then the joint probability of a person
having both conditions, if the two are
independent, would be 0.02% or 2 out
of every 10,000. Although this is a low
prevalence rate, it is higher than the
rates for childhood-onset schizophrenia
(Remschmidt and Theisen, 2005), and
many other well-known medical condi-
tions (e.g., Hodgkin’s lymphoma, Prader
Willi syndrome, Rett’s Syndome). Based
on this estimated prevalence rate, in the
United States alone (with a population of
311, 591, 917, as of July 2011, according
the US census), there should be approxi-
mately 620 congenitally blind people with
schizophrenia. When cases of blindness
with an onset in the first year of life (i.e.,
early blindness) are taken into account,
the percentage would be larger. Therefore,
it is remarkable that in over 60 years, and
with several investigations [including sev-
eral before DSM-III (1980) when criteria
for schizophrenia were broader than at
present], not a single case of a C/E blind
schizophrenia patient has been reported.
Moreover, several published studies, and
our experience as well, included survey-
ing Directors of agencies that serve large
numbers of blind people, and none of
them could recall ever seeing a person who
had both conditions. It is also interesting
that rates of C/E blindness are signifi-
cantly higher in developing, compared
to industrialized, countries. Therefore, if
C/E blindness did not protect against the
development of schizophrenia, comorbid-
ity would be more likely to be reported
in such countries. However, this has not
occurred. In short, available evidence,
probabilistic estimates, and the striking
contrasts, within the same domains of
cognition, between superior functioning
in C/E blindness and impaired function-
ing in schizophrenia, combine to suggest
a protective relationship. If the conditions
did co-occur at chance levels, reports of
such cases should appear at least some-
what as often as those of many other
rare medical conditions, especially since
reports of an absence of schizophrenia in
C/E blind people have appeared since 1950
(Chevigny and Braverman, 1950). The
absence of such reports is noteworthy.
One research strategy that could gen-
erate further evidence on this issue is
the study of schizotypal symptoms in the
C/E blind. These subsyndromal psychotic
symptoms have a higher base rate than
schizophrenia itself (i.e., 10–15% vs.∼1%)
(Fossati and Lenzenweger, 2009), and peo-
ple with these symptoms share some of
the same cognitive and biological impair-
ments as people with the full disorder
(Aichert et al., 2012; Cochrane et al.,
2012). Studies of schizotypal symptoms
would allow for the determination of
whether C/E blindness protects against
the full spectrum of schizophrenia-related
illness or just schizophrenia itself. If
no schizotypal symptoms were observed,
this would be evidence for the exis-
tence of protective mechanisms against
all schizophrenia-related psychopathology.
If, however, schizotypal symptoms were
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found, samples of C/E blind people could
be studied to gain insight into the neu-
robiological changes that protect against
the development of clinical psychosis. As
such, expanding the schizophrenia pheno-
type studied in the C/E blind holds poten-
tial for increasing our understanding of the
mechanisms involved in schizophrenia.
In addition to these points, we noted
in our original paper that other congenital
sensory impairments have not been asso-
ciated with absence of schizophrenia, that
congenital deafness and later blindness,
such as found in Usher Syndrome, whose
prevalence has been estimated at 0.005%
(Rosenberg et al., 1997) has been asso-
ciated with psychotic disorders at rates
between 4–24% (Waldeck et al., 2001),
and that non-psychotic psychiatric dis-
orders are observed in C/E blindness.
These data suggest a unique relationship
between C/E blindness and schizophre-
nia. However, we acknowledge that the
absence of evidence (of people with both
conditions) is not evidence of absence.
That said, given the potentially impor-
tant lessons for understanding, preventing,
and treating schizophrenia that brain reor-
ganization in C/E blindness provides, we
believe it is useful to pursue this line of
thought. At the very least, if C/E blind-
ness did not prevent schizophrenia, then
in light of the cognitive changes sec-
ondary to C/E blindness, it would be
informative to determine whether it miti-
gates the associated cognitive impairment.
Finally, we hope to raise awareness in
the psychiatric community of past lit-
erature relating to C/E blindness and
schizophrenia, so that if people with
both conditions exist, their cases will be
reported.
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